Results 231 to 233 of about 32,827 (233)

Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review.

2012
Oxaliplatin is widely regarded as being active in cisplatin-resistant cancer. We undertook a systematic review of the literature to identify, describe and critique the clinical and pre-clinical evidence for the use of oxaliplatin in patients with ?cisplatinresistant? cancer.
openaire   +1 more source

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin

European Journal of Cancer, 2002
S Y Sharp, C F O'Neill, L R Kelland
exaly  

Cetuximab plus capecitabine and oxaliplatin is an active salvage therapy for oxaliplatin-resistant or refractory colorectal cancer

Inpharma Weekly, 2007
openaire   +1 more source